For Immediate Release
Chicago, IL—September 23, 2016—Zacks Friday Finish Line is a podcast hosted weekly by Zacks Editor Maddy Johnson and Content Writer Ryan McQueeney that takes on the week’s biggest news from the financial and investment world.
Wells Fargo and Mylan: Corporate Devils or Unworthy Scapegoats?
Welcome to Episode #13 of the Zacks Friday Finish Line Podcast!
VIDEO A Busy Week in IPOs
This week, Maddy and Ryan kicked off the show with a recap of two big IPOs: The Trade Desk (
TTD - Free Report) and e.l.f. Beauty ( ELF - Free Report) . Both companies, one a digital advertising platform and the other a low-priced cosmetics maker, had stellar market debuts and priced above their initial targets. According to Fortune, this week as been one of the most active weeks for U.S. IPOs of 2016, which has been notoriously slow for public debuts. Netflix Library Change
The hosts moved on to discussing Netflix (
NFLX - Free Report) CFO David Wells’ announcement that the popular streaming giant plans on making half of its total content original programming over the next few years. He noted that the company is already “one-third to halfway” to their 50% original content goal. Comcast Mobile Phone Service
Maddy and Ryan then talked about Comcast’s (
CMCSA - Free Report) new mobile phone service that will launch sometime next year. The Comcast network will largely be on Wi-Fi hotspots, and will operate on Verizon’s (VZ) wireless network when away from Wi-Fi connections. Mylan & Wells Fargo Testify in Congress
The hosts saved the best for last, digging deep into two big corporations’ CEOs testifying in front of Congress this week. On Tuesday, Wells Fargo (
WFC - Free Report) CEO John Stumpf, the man whose company is at the center of a scandal involving fraudulent account opening practices, was called into a congressional committee hearing to answer questions about Wells Fargo’s fraud. Sen. Elizabeth Warren was Stumpf’s most vocal critic, demanding his resignation and suggesting he should be criminally investigated.
And on Wednesday, Mylan (
MYL - Free Report) CEO Heather Bresch responded to questions from the House Oversight Committee as Congress continued its probe into the company’s price hikes on EpiPens. Rep. John Duncan, Rep. Tammy Duckworth, Rep. Jason Chaffetz, and Rep. Elijah Ciummings all had hard questions for Bresch, with Chaffetz memorably telling Mylan’s CEO “This is why we don’t believe you” in response to her arguing that the company doesn’t actually make that much profit on the drug. Want More Zacks Friday Finish Line?
Check back every Friday for a new episode that looks at each week’s biggest financial and investment news. You can follow the Zacks Friday Finish Line Podcast on
iTunes, Soundcloud, and ZacksInvestmentNews on YouTube. About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!
Register for your free subscription to Profit from the Pros.
Follow us on Twitter:
Join us on Facebook:
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.